RARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Ultragenyx Pharmaceutical Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$15.07+0.53 (+3.65%)
Close on Oct 19, 2026
- Market cap
- $1.54B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Ultragenyx Pharmaceutical's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 19, 2026 | Oct 19, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 8, 2026 | Oct 14, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 6, 2026 | Oct 7, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 17, 2026 | Sep 17, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2026 | Sep 2, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2026 | Aug 19, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2026 | Aug 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2026 | Aug 4, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 2, 2026 | Apr 2, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 14, 2026 | Mar 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 23, 2026 | Feb 23, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 18, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2026 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 3, 2026 | Feb 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2026 | Jan 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 30, 2025 | Dec 30, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 29, 2025 | Dec 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2025 | Sep 8, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 18, 2025 | Aug 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 11, 2025 | Jul 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2025 | Jul 9, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2025 | Jun 27, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 15, 2025 | Mar 28, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 19, 2025 | SEC EDGAR |